Drugs / BIOHM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04362826 | Mar → Dec 2026 expected | breast cancer | Case Comprehensive Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIOHM | “The probiotic, BIOHM, which is owned and distributed by BIOHM Health LLC, will be used in this study.” NCT04362826 ↗ |
| Modality | Other / unclassified | “BIOHM is a food supplement” NCT04362826 ↗ |